An mRNA vaccine is a recipe, not a weakened virus
A reader asked why an mRNA vaccine counts as a recipe and not a weakened virus. The short answer: a weakened-virus vaccine injects a whole virus, still alive but tamed. An mRNA vaccine injects a written copy of just one of the virus's genes, the one for its spike protein, wrapped in a droplet of fat. Your own cells read that copy, make the spike, and your immune system learns its shape. Nothing in the vial can build a virus, because everything else a virus needs was left out.
How vaccines did it before
A vaccine works by showing the immune system something that looks like the enemy before the real enemy turns up. The Nobel committee's 2023 background paper sorts the older ways of doing that into a few kinds. Live weakened viruses, as in the measles-mumps-rubella and yellow fever vaccines, give strong, long-lasting protection. Killed viruses, as in the hepatitis A vaccine, work too, but the protection fades sooner and needs boosters. Subunit vaccines leave the virus out altogether and inject a single protein from it, made in a factory: the hepatitis B vaccine of 1986 was the first. Viral vectors hide one gene from the target inside a harmless carrier virus; the first licensed one, against Ebola, came in 2019.
An mRNA vaccine is closest to the subunit kind, with one difference. It does not ship the protein. It ships the instructions, and your cells do the making.
What the vial holds
A gene is written in four letters. The virus that causes COVID-19 keeps all of its genes on one strand of RNA, 29,903 letters long in the first sequenced sample. Eleven genes are marked on it in the reference record. The biggest makes the virus's copying machinery; others make its outer shell and the protein that packs its genome. The spike gene, 3,822 letters, is about an eighth of the whole.
The Pfizer-BioNTech vaccine's RNA, called tozinameran, is 4,283 letters long. It holds the spike recipe, plus short stretches at each end that the cell needs in order to read it well: a cap at the front, and at the back a long tail of As, which Karikó found raises how much protein a strand makes. There is no copying gene and no shell gene. A cell can make exactly one thing from it, the spike, and then the instructions run out.
Interactive Top: the virus's whole genome, gene by gene. Click a gene, or tab to the map and use the arrow keys, to see what it makes. Bottom: slide along the spike recipe and compare the virus's letters with the vaccine's, three at a time.
the spike recipe, side by side: the virus's version against the vaccine's
The same protein, spelled differently
Genes are read three letters at a time, and each three-letter word names one building block of the protein. Most building blocks have several spellings, so a recipe can be rewritten without changing what it makes. Line the vaccine's spike recipe up against the virus's, as the figure does, and about seven in every ten words are spelled differently. The protein they spell is almost the same: of 1,273 building blocks, only two differ.
Those two are deliberate. Both are swapped for proline, a stiff building block. A spike is spring-loaded: when it fuses with a cell it snaps into a different shape. The vaccine is meant to teach the immune system the shape the spike has before it gets in, and two prolines in the right place hold it there. The Nobel paper traces the trick back through work on influenza and on an earlier coronavirus, MERS.
One more change is chemical. Every U in the vaccine's RNA is swapped for a close cousin called N1-methylpseudouridine. The cell reads it as a U, so the protein is unchanged. This line of work won Katalin Karikó and Drew Weissman the 2023 Nobel Prize. Unaltered RNA made in a lab sets off the body's alarms for viral RNA, causing inflammation and shutting down protein making. Our own cells' RNA carries many altered letters, and in 2005 the two showed that putting such letters into lab-made RNA kept those alarms quiet. Later work showed it also raised how much protein each strand made.
From recipe to immunity
RNA is fragile and gets into cells poorly on its own, so the strands travel inside lipid nanoparticles: tiny balls of fat built around a lipid that carries a charge while the particle is made and loses it in the body. Once inside a cell, the RNA only has to reach the cell's interior, where the ribosomes read it like any other message. Spike proteins appear on the cell's surface. B cells whose receptors fit the spike are stirred into making antibodies, and pieces of spike shown on the cell can call up killer T cells too.
The RNA never needs to reach the nucleus, where our DNA is kept, and the Nobel committee notes it cannot be written into the genome. The body breaks it down, though not in a matter of hours. A 2022 study at Stanford found vaccine RNA, and spike protein, in the germinal centres of lymph nodes near the injection up to two months after the second dose in some people. Those centres are where antibody-making cells are trained.
Why build vaccines this way
Speed. A weakened or killed virus has to be grown in living cells, which needs cell-culture factories. A recipe is made in a test tube by an enzyme copying a DNA template, and changing the vaccine means changing the template. That is how both COVID-19 mRNA vaccines were approved within a year of the outbreak, and why the Nobel committee singled out how fast the method turns out updated versions for new variants. In August 2026 the US Food and Drug Administration approved Moderna's mFLUSIVA, which the company calls the first mRNA flu vaccine, for adults 50 and older. For those 65 and over the approval is an accelerated one, based on immune responses, with a follow-up trial required to confirm the benefit.
Plain recipes are not the only RNA design. Some, called replicons or self-amplifying RNA, add a copying gene borrowed from a different kind of virus, an alphavirus, so that each cell ends up with more copies of the recipe.
In one breath
A weakened-virus vaccine is the virus, tamed. An mRNA vaccine is a single rewritten page from the virus's book: the spike recipe, respelled, with two building blocks changed to hold the spike in its before-entry shape and every U swapped for a quieter letter. Your cells read it, show the spike, and break the page down. What stays is the immune system's memory of the shape.
Where this comes from
- Scientific background: Discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19 linked only, not reproduced
www.nobelprize.org/uploads/2023/10/advanced-medicinprize2023-3.pdf - Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome (NC_045512.2) linked only, not reproduced
www.ncbi.nlm.nih.gov/nuccore/NC_045512.2 - Tozinameran (UNII 5085ZFP6SJ): nucleic acid sequence and modifications linked only, not reproduced
gsrs.ncats.nih.gov/ginas/app/ui/substances/6fefa717-6a4c-435f-a692-46189283764f - Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination linked only, not reproduced
pubmed.ncbi.nlm.nih.gov/35148837/ - MFLUSIVA (Influenza Vaccine, mRNA): approval, indication and review documents linked only, not reproduced
www.fda.gov/vaccines-blood-biologics/vaccines/mflusiva - Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA linked only, not reproduced
www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/moderna-receives-u.s.-fda-approval-for-influenza-vaccine-mflusiva-1201472